The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy.
about
Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expressionNarrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disordersThe diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarinThe endocannabinoid system as an emerging target of pharmacotherapyHarm reduction--the cannabis paradoxAdvances of Molecular Imaging in EpilepsyAre cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic reviewCannabinoids and Epilepsy.Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agentsCannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsyCannabinoid CB1 Receptor Agonists Do Not Decrease, but may Increase Acoustic Trauma-Induced Tinnitus in RatsPost-ictal analgesia in genetically epilepsy-prone rats is induced by audiogenic seizures and involves cannabinoid receptors in the periaqueductal gray.Pursuing paradoxical proconvulsant prophylaxis for epileptogenesisStatistical parametric mapping reveals regional alterations in cannabinoid CB1 receptor distribution and G-protein activation in the 3D reconstructed epileptic rat brain.The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments.Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents.Dentate cannabinoid-sensitive interneurons undergo unique and selective strengthening of mutual synaptic inhibition in experimental epilepsy.The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas.Cannabinoid-mediated inhibition of recurrent excitatory circuitry in the dentate gyrus in a mouse model of temporal lobe epilepsyTranscriptome analysis of the hippocampal CA1 pyramidal cell region after kainic acid-induced status epilepticus in juvenile rats.Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintainance of epilepsy.Long-term decrease in calbindin-D28K expression in the hippocampus of epileptic rats following pilocarpine-induced status epilepticus.A Long-Term Treatment with Arachidonyl-2'-Chloroethylamide Combined with Valproate Increases Neurogenesis in a Mouse Pilocarpine Model of EpilepsyEndocannabinoids in the dentate gyrus.AAV vector-mediated overexpression of CB1 cannabinoid receptor in pyramidal neurons of the hippocampus protects against seizure-induced excitoxicity.Altering cannabinoid signaling during development disrupts neuronal activitySpatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and peripheral nervous system.Astrocytic expression of cannabinoid type 1 receptor in rat and human sclerotic hippocampi.Dynamic changes of CB1-receptor expression in hippocampi of epileptic mice and humans.Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modalityRedistribution of CB1 cannabinoid receptors in the acute and chronic phases of pilocarpine-induced epilepsyNeuron to astrocyte communication via cannabinoid receptors is necessary for sustained epileptiform activity in rat hippocampus.Cannabidivarin is anticonvulsant in mouse and rat.Therapeutic potential of cannabinoid medicines.'Crazy Monkey' poisons man and dog: Human and canine seizures due to PB-22, a novel synthetic cannabinoid.The Pharmacological Basis of Cannabis Therapy for Epilepsy.Multiple sclerosis may disrupt endocannabinoid brain protection mechanism.Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotectionAcetaminophen inhibits status epilepticus in cultured hippocampal neurons.Effect of cannabinoid receptor activation on spreading depression.
P2860
Q21128738-104B7D59-92D1-4D7A-87D2-2D745BC59FD6Q22299116-70F95FAF-E335-4364-8699-0A06828B61A7Q24643876-EEF17E4A-C938-45B3-B264-87BBB9D2BE02Q24648473-DAADEDE3-B797-48C4-BED5-DC5E2C538CF2Q24814542-A7553B94-CB92-44F3-B172-97BFB9C9C54AQ26750477-8EE6278E-5F8D-4CE1-9110-85A0633A6780Q27005619-EBD89C3A-7DB5-4A2F-A356-8521AD0B33FAQ27336451-47D548BF-EB91-4952-9733-447C7D2C479AQ28075692-1958AFAC-9AF4-4182-B324-F2706CD9756BQ28573365-00FC41A6-DD0D-4F10-AF13-EC86A310D30DQ30414733-DB64104D-6BC6-416C-9D42-7BE0350DDDD6Q30467672-9F2EFA19-DF0F-4A03-8C0C-7956E0C5AA33Q30495206-274FE123-5F27-4D50-8B13-0ECF93AE2D0FQ30551935-0874555C-E13F-41BA-87A7-361DAB457041Q30576758-55004C84-C8B0-44AB-B724-12776793C7B2Q30612936-FA8AD48B-B0B5-41B3-A0A6-0D3C79CD7472Q30724974-0696E70A-7D8C-4B5D-A916-A3BF4D2E455FQ33525520-8D3471D7-F1B3-4EC7-8C83-C96288295AA7Q33586242-5D6890CA-A47B-444A-BF4A-5C75959B11F0Q33588555-2830F21F-B7F3-4BC8-AEC4-8022BABE9AAAQ33642642-0091DAFB-20BE-446A-A229-A2A3032AA0D2Q33685218-1E10F58E-6E87-46EF-BD66-46B53DD635A8Q33754746-A2224D16-FBC0-4A8E-B529-60867F74619AQ33757950-456C7E4C-BEB3-4DE6-B0AD-31B46602E2EDQ33784846-DC4D1BF8-EA6C-4859-BAAB-035FD2742C84Q33878871-022E7E7D-CE38-4CA3-8501-DE7D1ED34507Q33897801-B95DA5A2-CB0E-4F1D-B95E-ECC92D727479Q33898545-724BA2DF-1E06-4FF0-89F4-5DA83F74C958Q34015797-578B2658-B00D-42A3-901C-B78DC1B1B5A9Q34018061-1ACD5B05-FD58-48E9-9726-ED8C82E84AB0Q34072654-E42E5062-6AD3-4F78-87A1-23D15E9CE0EDQ34277978-6EB0A655-4371-4612-BA05-732183629FC8Q34299232-15CD39B8-EFA8-4699-B8EE-B917C7027AF0Q34368715-C58DC13C-D3EC-41E3-87E5-3CB801EF6D15Q34423408-4D0A8183-B366-48FD-95AC-5FEB1A19FEFFQ34509920-47B56F2A-5CAD-4F5A-8395-7FD1CC50FE6DQ34597217-F98CF414-7315-43DD-8844-E1D50F788BFFQ34597537-8A3CA706-159A-4B03-9D9A-6C3D36237462Q34641056-3A366214-C13D-4EF0-8133-0D771D3E3C5CQ34649359-19C6F205-5659-4F08-8ADB-7670ECB68D0F
P2860
The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
The endogenous cannabinoid sys ...... del of temporal lobe epilepsy.
@en
The endogenous cannabinoid sys ...... del of temporal lobe epilepsy.
@nl
type
label
The endogenous cannabinoid sys ...... del of temporal lobe epilepsy.
@en
The endogenous cannabinoid sys ...... del of temporal lobe epilepsy.
@nl
prefLabel
The endogenous cannabinoid sys ...... del of temporal lobe epilepsy.
@en
The endogenous cannabinoid sys ...... del of temporal lobe epilepsy.
@nl
P2093
P356
P1476
The endogenous cannabinoid sys ...... del of temporal lobe epilepsy.
@en
P2093
Billy R Martin
Katherine W Falenski
Melisa J Wallace
Robert E Blair
Robert J DeLorenzo
P304
P356
10.1124/JPET.103.051920
P407
P577
2003-09-03T00:00:00Z